A Mizokami, K Shigehara, K Sugimoto… - Journal of Men's …, 2011 - jmhjournal.org ... EMAIL TO A COLLEAGUE. RIGHTS/PERMISSIONS. NEED REPRINTS? BOOKMARK ARTICLE. 46 Androgen replacement therapy contributes to improving urinary function in patients with hypogonadism and benign prostatehypertrophy; a randomized, controlled study. ... Cached - All 2 versions
[PDF] from pjms.com.pkSM Asafudullah, MA Salam… - Pakistan Journal of …, 2011 - pjms.com.pk ... Free to total prostate-specific antigen (PSA) ration is superior to total-PSA in differentiating benign prostatehypertrophy from prostate cancer. ...Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147:815-816. ... Related articles - All 2 versions
[CITATION] … PROSTATE AND TRANSURETHRAL RESECTION OF THE PROSTATE FOR SYMPTOMATIC BENIGN PROSTATIC HYPERTROPHY IN THE VETERANS …
D Willis, M Mejia, C Knapp, T Wagner… - The Journal of …, 2011 - Elsevier
T Roumeguère, P Delree, P Van Antwerpen… - … Prostate, 2011 - Wiley Online Library ... This localization of MPO is intriguing as the enzyme can promote mutagenesis by the modification of DNA bases and as a consequence could induce prostatic cell dysfunction as the basis of prostatic inflammatory syndromes, hypertrophy, or prostate cancer. ... Related articles - All 2 versions
[PDF] from dtic.milH Mukhtar - 2011 - DTIC Document ... prostatic hypertrophy, and prostate cancer (4). In our study, we found that there was significant inhibition of secreted PSA levels by 13-36%, 26-54% and 57-72% in EGCG, nanoEGCG (3mg/kg body wt.) and nanoEGCG (6mg/kg body wt.) treated groups, respectively as ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
